510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K190397Substantially Equivalent

Immunalysis Carisoprodol Metabolite / Meprobamate Urine HEIA

Immunalysis Corporation, Pomona CA / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)510(k) summary (opens on fda.gov)

K190397 is the FDA 510(k) clearance record for Immunalysis Carisoprodol Metabolite / Meprobamate Urine HEIA, a class II device, cleared for Immunalysis Corporation on under FDA product code QBK (Meprobamate Test System). FDA's definition for product code QBK reads: "A meprobamate test system is a device intended to measure meprobamate in human specimens. Measurements obtained by this device are used to detect the presence of meprobamate to diagnose the use or overdose of meprobamate or...". FDA records list 50 510(k) clearances for Immunalysis Corporation, from to . As of , FDA records show no recalls naming K190397.

Clearance record

Decision date
Received
(269 days to decision)
Product code
QBK Meprobamate Test System
Regulation
21 CFR 862.3590
Device class
Class II
Review panel
Clinical Toxicology
Applicant
Immunalysis Corporation 829 Towne Center Dr., Pomona CA
510(k) summary
Summary PDF
Third party review
No

Clearances, product code QBK

Trailing 12 months

FDA records hold no clearances under product code QBK in the trailing twelve months.

FDA records show no clearances under product code QBK in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code QBK, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260